NCT06800885View on ClinicalTrials.gov

Repeated Cross Sectional Surveillance Study To Determine the Influenza Vaccination Rates in German Participants

Active, not recruitingOBSERVATIONAL

Enrollment

5,000

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions

Influenza Immunization

Trial Locations (1)

Unknown

Germany

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY